Clinical Trials Browser

Interventional × Has results × Papillomavirus Vaccines × Clear all

NCT01824537 2025-03-19

TRAP-HPV

Phase 4 Completed

372 enrolled 12 charts

Papillomavirus Infections

NCT03489707 2024-11-12

The Prevent Anal Cancer Self-Swab Study

Phase NA Completed

253 enrolled 10 charts

Gastrointestinal

Anus Neoplasms

NCT03629886 2024-03-15

Safety and Protective Effect Study of GSK Biologicals' Human Papillomavirus (Types 16, 18) Vaccine, Adsorbed (GSK580299) in Healthy Female Subjects From the HPV-039 Study

Phase 4 Completed

6,051 enrolled 11 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT02865135 2024-01-11

Trial To Test Safety And Efficacy Of Vaccination For Incurable HPV 16-Related Oropharyngeal, Cervical And Anal Cancer

Phase 1/2 Completed

11 enrolled 18 charts

GastrointestinalGynecologicHead & Neck

Anus Neoplasms, Uterine Cervical Neoplasms, Head and Neck Neoplasms

NCT01928225 2020-06-24

Randomized, Double Blind Trial of the Quadrivalent HPV Vaccine to Improve Responses to LEEP Treatment of Cervical HSIL

Phase 2 Completed

180 enrolled 11 charts

Uterine Cervical Dysplasia, Uterine Cervical Neoplasms

NCT00231413 2019-12-12

Human Papilloma Virus Vaccine Immunogenicity and Safety Trial in Young Adult Women With GSK Bio's Novel HPV Vaccine.

Phase 2 Completed

383 enrolled 30 charts

Papillomavirus Infections

NCT00309166 2018-09-17

Evaluation of the Immunogenicity and Safety of GlaxoSmithKline Biologicals' HPV Vaccine in Young Males.

Phase 2 Completed

270 enrolled 14 charts

Papillomavirus Infections

NCT00541970 2018-08-17

Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs

Phase 1 Completed

961 enrolled 43 charts

Uterine Cervical Neoplasms, Virus Diseases, Papillomavirus Infections

NCT00578227 2018-08-17

Evaluation of Safety and Immunogenicity of Co-administering Human Papillomavirus Vaccine With Another Vaccine in Healthy Female Subjects

Phase 3 Completed

814 enrolled 28 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00652938 2018-08-17

Evaluation of Immunogenicity and Safety of Human Papillomavirus (HPV) Vaccine Co-administered With Another Vaccine in Healthy Female Subjects

Phase 3 Completed

744 enrolled 27 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT01984697 2018-08-08

V503-010

Phase 3 Completed

1,518 enrolled 44 charts

Papillomavirus Infections

NCT00552279 2018-06-25

Immunogenicity and Safety of GlaxoSmithKline Biologicals' Huma Papillomavirus (HPV) Vaccine 580299 in Healthy Females 15 - 25 Years of Age

Phase 3 Completed

805 enrolled 16 charts

Uterine Cervical Neoplasms, Papillomavirus Infections

NCT00496626 2017-04-17

An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)

Phase 3 Completed

600 enrolled 12 charts

Papillomavirus Infections

NCT00092521 2015-09-25

Cervical Intraepithelial Neoplasm (CIN)-Warts Efficacy Trial in Women (Gardasil)(V501-013)(COMPLETED)

Phase 3 Completed

5,759 enrolled 10 charts

Uterine Cervical Neoplasms, Condylomata Acuminata

NCT00325130 2015-03-12

Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents (V501-025)

Phase 3 Completed

1,042 enrolled 26 charts

Diphtheria, Meningitis, Neoplasms, Glandular and Epithelial, Tetanus, Whooping Cough

NCT01034358 2012-10-23

Immune Response to the Human Papillomavirus Vaccine in Young Women With Inflammatory Bowel Disease

Phase 4 Completed

15 enrolled 6 charts

Uterine Cervical Dysplasia, Colitis, Ulcerative, Crohn Disease, Inflammatory Bowel Diseases